You have 9 free searches left this month | for more free features.

VMAT2

Showing 1 - 25 of 191

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rectal Tumors, Rectal Tumor Malignant Trial in Iowa City (Niraparib, Dostarlimab, Short course radiation)

Recruiting
  • Rectal Neoplasms
  • Rectal Neoplasm Malignant
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center at the University of Iowa
Jul 22, 2022

Pancreatic Tumor Trial in Iowa City (Ascorbate, Gemcitabine, radiation therapy)

Not yet recruiting
  • Pancreatic Neoplasm
  • Iowa City, Iowa
    The University of Iowa
Jan 28, 2022

Tumor Metastasis, Neoplastic Processes, Tumors Trial in Canada (SUPR, VMAT)

Recruiting
  • Neoplasm Metastasis
  • +3 more
  • SUPR
  • VMAT
  • Prince George, British Columbia, Canada
  • +4 more
Apr 6, 2022

Prostate Cancer Trial in Toronto (Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy, No Active

Active, not recruiting
  • Prostate Cancer
  • Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy
  • No Active Treatment - completed Prior Radiation
  • Toronto, Ontario, Canada
    University Health Network, The Princess Margaret
Oct 4, 2021

Presynaptic Imaging in Major Depressive Episodes After COVID-19

Recruiting
  • Long COVID
  • +2 more
  • [11C]DTBZ PET scan
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Oct 15, 2023

Schizophrenia Trial in United States (Placebo, Valbenazine)

Recruiting
  • Schizophrenia
  • Phoenix, Arizona
  • +40 more
Jan 20, 2023

Schizophrenia Trial in Miami, Chicago, Buffalo (Valbenazine, Placebo)

Recruiting
  • Schizophrenia
  • Miami, Florida
  • +2 more
Jan 20, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Meningioma, Radiation Toxicity Trial in Caen, Rouen (Normo-fractionated intensity-modulated brain irradiation with or without

Recruiting
  • Meningioma
  • Radiation Toxicity
  • Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning
  • +3 more
  • Caen, France
  • +1 more
Sep 13, 2023

Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • AK104 injection
  • +3 more
  • (no location specified)
Apr 4, 2023

Larynx Cancer Stage I, Glottic Carcinoma Trial in Cairo (Hypofractionated single vocal cord irradiation, Whole laryngeal

Recruiting
  • Larynx Cancer Stage I
  • Glottic Carcinoma
  • Hypofractionated single vocal cord irradiation
  • Whole laryngeal radiotherapy
  • Cairo, Egypt
    National Cancer Institute, Cairo University
Jan 10, 2023

Envafolimab Combined With Endostar and Concurrent

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
May 19, 2023

Dyskinesia, Cerebral Palsy Trial in Farmington Hills (Placebo, Valbenazine)

Recruiting
  • Dyskinesia
  • Cerebral Palsy
  • Farmington Hills, Michigan
    Neurocrine Clinical Site
Jun 27, 2022

Prostate Cancer Trial in St. Leonards (R/T gating kV intrafraction monitoring)

Recruiting
  • Prostate Cancer
  • R/T gating kV intrafraction monitoring
  • St. Leonards, New South Wales, Australia
    Department of Radiation Oncology, Northern Sydney Cancer Centre
Oct 25, 2022

Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023

Uterine Cervical Tumors, Locally Advanced Cervical Carcinoma Trial in Leiden, Rotterdam (External beam radiation therapy:

Recruiting
  • Uterine Cervical Neoplasms
  • Locally Advanced Cervical Carcinoma
  • External beam radiation therapy: IMRT/VMAT
  • +3 more
  • Leiden, Netherlands
  • +1 more
Jun 1, 2022

Gastric Cancer, Gastroesophageal-junction Cancer Trial in Wuhan, Nanjing, Taiyuan (Tislelizumab, S-1, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • Gastroesophageal-junction Cancer
  • Wuhan, Hubei, China
  • +2 more
Jan 16, 2023

Breast Cancer Trial (WT_vDIBH, VMAT_FB)

Completed
  • Breast Cancer
  • WT_vDIBH
  • VMAT_FB
  • (no location specified)
Apr 12, 2022

Breast Cancer Trial in Worthington, Fargo, Sioux Falls (IMRT/VMAT-Based Accelerated Partial Breast Irradiation)

Recruiting
  • Breast Cancer
  • IMRT/VMAT-Based Accelerated Partial Breast Irradiation
  • Worthington, Minnesota
  • +2 more
Nov 11, 2022

Hematologic Malignancy Trial in New York (Linac Based VMAT TBI)

Recruiting
  • Hematologic Malignancy
  • Linac Based VMAT TBI
  • New York, New York
    NYU Langone Health
Jan 13, 2022

Glioblastoma Trial (Dose escalation of radiation dose beyond the therapeutic standard)

Not yet recruiting
  • Glioblastoma
  • Dose escalation of radiation dose beyond the therapeutic standard
  • (no location specified)
May 13, 2023

Non Small Cell Lung Cancer Stage III Trial in Melbourne (Functionally adapted, dose escalated VMAT radiotherapy)

Completed
  • Non Small Cell Lung Cancer Stage III
  • Functionally adapted, dose escalated VMAT radiotherapy
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 17, 2022

Brain Metastases Trial in Rozzano (brain metastatic patients)

Completed
  • Brain Metastases
  • brain metastatic patients
  • Rozzano, Milano, Italy
    Istituto Clinico Humanitas
May 24, 2019

Glioma Trial in Aviano (Pulsed low dose-rate radiotherapy (pLDRT))

Recruiting
  • Glioma
  • Pulsed low dose-rate radiotherapy (pLDRT)
  • Aviano, Pordenone, Italy
    IRCCS-Centro di Riferimento Oncologico (CRO) di Aviano
Sep 20, 2023

Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

Recruiting
  • Esophageal Neoplasm Metastatic
  • Esophageal Cancer Stage IVb
  • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
  • +3 more
  • Beijing, Beijing, China
    Cancer hospital, CAMS
Oct 19, 2023